GGC Winter 2016 Friends of the Center Newsletter
The latest GGC Friends of the Center newsletter is available for pdf download by clicking the cover below.
You can also view it here.
Recruitment underway for Rett Syndrome Newron trial
Newron Pharmaceuticals is conducting a research trial to evaluate the safety, tolerability and efficacy of an investigational product called Sarizotan in reducing respiratory abnormalities in patients with Rett Syndrome
Patients may be eligible who:
- are 13 years and older,
- have a body weight of at least 25 kg (55 lbs), and
- experience multiple episodes of breath holding (apnea) while awake during the day.
For additional details and contact information, see the study flyer and clinicaltrials.gov website below.
*Note GGC is not a participating center in this trial.
Susan R. Patterson Award Established at GGC
$30,000 gift will support bioinformatics and computational genomics.
November 10, 2016 – A gift to the Greenwood Genetic Center Foundation by Dr. Walt Patterson, Professor Emeritus of Mathematics, Lander University, has established the Susan R. Patterson Professional Development Award in Bioinformatics & Computational Genomics in memory of his wife, Susan. The award serves to honor and perpetuate her lifelong devotion to the field of education in mathematics. Susan was also passionate about supporting families and children faced with genetic disorders who are served by GGC.
GGC and Project Hope Foundation Establish 'Helix & Hope' Autism Collaboration
November 9, 2016 – The Greenwood Genetic Center (GGC) and Project Hope Foundation announce the creation of 'Helix and Hope,' a collaborative program providing an integrated approach to delivering services, support, and research to individuals and families impacted by an autism spectrum disorder (ASD).
Office of Communications
Lori Bassett, MS, CGC
Fax (864) 388-1062